11-36098452-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_174902.4(LDLRAD3):āc.445A>Cā(p.Ser149Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,614,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00068 ( 0 hom., cov: 33)
Exomes š: 0.000080 ( 0 hom. )
Consequence
LDLRAD3
NM_174902.4 missense
NM_174902.4 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 7.81
Genes affected
LDLRAD3 (HGNC:27046): (low density lipoprotein receptor class A domain containing 3) Predicted to enable amyloid-beta binding activity. Predicted to act upstream of or within receptor-mediated endocytosis and regulation of protein processing. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.009123355).
BP6
Variant 11-36098452-A-C is Benign according to our data. Variant chr11-36098452-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 726881.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLRAD3 | NM_174902.4 | c.445A>C | p.Ser149Arg | missense_variant | 4/6 | ENST00000315571.6 | NP_777562.1 | |
LDLRAD3 | NM_001304263.2 | c.298A>C | p.Ser100Arg | missense_variant | 3/5 | NP_001291192.1 | ||
LDLRAD3 | NM_001304264.2 | c.-35A>C | 5_prime_UTR_variant | 3/6 | NP_001291193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDLRAD3 | ENST00000315571.6 | c.445A>C | p.Ser149Arg | missense_variant | 4/6 | 1 | NM_174902.4 | ENSP00000318607.5 | ||
LDLRAD3 | ENST00000528989.5 | c.298A>C | p.Ser100Arg | missense_variant | 3/5 | 1 | ENSP00000433954.1 | |||
LDLRAD3 | ENST00000524419.5 | c.298A>C | p.Ser100Arg | missense_variant | 3/6 | 5 | ENSP00000434313.1 | |||
LDLRAD3 | ENST00000532490.1 | n.399A>C | non_coding_transcript_exon_variant | 4/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000690 AC: 105AN: 152234Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
105
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000227 AC: 57AN: 250582Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 135500
GnomAD3 exomes
AF:
AC:
57
AN:
250582
Hom.:
AF XY:
AC XY:
25
AN XY:
135500
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000800 AC: 117AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 727236
GnomAD4 exome
AF:
AC:
117
AN:
1461868
Hom.:
Cov.:
31
AF XY:
AC XY:
48
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000683 AC: 104AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.000617 AC XY: 46AN XY: 74504
GnomAD4 genome
AF:
AC:
104
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
46
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
10
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
36
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D;T;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Benign
T;D;D
Polyphen
0.84
.;.;P
Vest4
MutPred
0.23
.;.;Loss of phosphorylation at S149 (P = 0.023);
MVP
MPC
0.30
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at